Today: 20 May 2026
OCBC stock slips after JPMorgan downgrade — what to watch before Monday trade
10 January 2026
1 min read

OCBC stock slips after JPMorgan downgrade — what to watch before Monday trade

SINGAPORE, Jan 10, 2026, 14:50 SGT — Market closed

  • OCBC ended Friday down 1.8% after JPMorgan cut its rating to neutral.
  • The stock is back below S$20 after touching a record high earlier in the week.
  • Next key date: OCBC’s full-year results on Feb. 25.

Shares of Oversea-Chinese Banking Corp (OCBC) fell 1.8% on Friday to close at S$19.80 after JPMorgan downgraded the Singapore lender to “neutral” from “overweight” and lifted its target price to S$20.50. DBS gained 0.5% and UOB was little changed as Singapore’s benchmark index ended slightly higher. The Straits Times

The move matters because the local bank trade has become crowded early in 2026, helped by dividends and a hunt for steady names amid choppy headlines. UOB Kay Hian analyst Jonathan Koh called the sector “attractive value” and said, “We also like OCBC for its focus on trade and investment flows within Asean,” pointing to a lower forecast price-to-book ratio — a valuation measure that compares a bank’s market value to its net assets.

OCBC’s next hard catalyst is its full-year 2025 results on Feb. 25, according to the bank’s financial calendar. Investors will listen for any shift in tone on net interest margin — the spread between what a bank earns on loans and pays on deposits — and how management sees credit costs heading into 2026.

Price action has been quick. OCBC traded above S$20 for much of the week and hit an intraday high of S$20.25 on Jan. 7 before sliding back to Friday’s low and close at S$19.80. Turnover rose to about 8.4 million shares on Friday from roughly 4.3 million a day earlier.

Chart watchers often treat recent lows as “support” — levels where buyers have tended to step in — and recent highs as “resistance”, where selling pressure shows up. On that yardstick, S$19.80 is the near-term line in the sand, with S$20.25 the level bulls need to clear again. MarketScreener

JPMorgan’s new S$20.50 target sits about 3.5% above Friday’s close, a thin cushion after the run-up. The downgrade, even with a higher target, leaves the stock more sensitive to shifts in rate bets and any wobble in risk appetite when markets reopen.

But the downside case is easy to sketch. Faster-than-expected rate cuts can squeeze loan margins, while a soft patch in regional growth can push up bad debts and force banks to build provisions. A strong Singapore dollar can also cool some cross-border activity that wealth managers lean on.

Trading resumes on Monday, with attention on whether OCBC can hold the S$19.80 level after the broker call. Beyond that, shareholders have the bank’s annual general meeting on Jan. 29 before the Feb. 25 results.

Stock Market Today

  • Applied Digital, Viasat, CECO Environmental, and HNI Shares Plunge Amid Rising Yields and Oil Prices
    May 20, 2026, 5:35 PM EDT. Applied Digital (APLD), Viasat, CECO Environmental, and HNI stocks suffered sharp declines in afternoon trading due to surging 10-year Treasury yields hitting 4.56%, a one-year high, and rising WTI crude oil prices near $104 per barrel amid geopolitical tensions. The market also reacted negatively to the lack of concrete agreements from the recent U.S.-China summit. Applied Digital remains notable, trading near its 52-week high at $42.53 after signing long-term AI data center deals expected to generate $7 billion in revenue over 15 years, reflecting strong positioning in the growing AI infrastructure sector. The broader sell-off weighed on major indexes, including the S&P 500 and Nasdaq, pulling them back from record highs.

Latest articles

MicroAlgo Stock Jumped 40%—The Quantum Release Behind MLGO’s Sudden Move

MicroAlgo Stock Jumped 40%—The Quantum Release Behind MLGO’s Sudden Move

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
Bank of America stock dips after-hours after $3 billion debt call, with earnings next week
Previous Story

Bank of America stock dips after-hours after $3 billion debt call, with earnings next week

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results
Next Story

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results

Go toTop